Operating Segments (Tables)

9 Months Ended

Jun. 30, 2013

Segment Reporting [Abstract]

Segment Revenue, Operating Income from Continuing Operations and Depreciation and Amortization

The tables below present segment revenue, operating income from continuing operations and depreciation and amortization, as follows (in thousands):

	Three months ended June 30,						Nine months ended June 30,
	2013			2012			2013			2012
Revenue:
Medical Device	$	10,591		$	10,269		$	30,857		$	27,889
In Vitro Diagnostics		3,698			3,690			10,978			10,196
Total revenue	$	14,289		$	13,959		$	41,835		$	38,085
Operating income (loss):
Medical Device	$	5,223		$	5,173		$	15,848		$	13,226
In Vitro Diagnostics		915			1,070			2,933			3,246
Total segment operating income		6,138			6,243			18,781			16,472
Corporate		(1,900	)		(1,450	)		(5,537	)		(4,768	)
Total operating income from continuing operations	$	4,238		$	4,793		$	13,244		$	11,704
Depreciation and amortization:
Medical Device	$	319		$	355		$	947		$	1,073
In Vitro Diagnostics		216			193			649			582
Corporate		193			186			578			559
Total depreciation and amortization	$	728		$	734		$	2,174		$	2,214